Search alternatives:
significantly small » significantly smaller (Expand Search), significantly impact (Expand Search), significantly impair (Expand Search)
higher decrease » higher degree (Expand Search), higher degrees (Expand Search), highest increase (Expand Search)
small decrease » small increased (Expand Search)
significantly small » significantly smaller (Expand Search), significantly impact (Expand Search), significantly impair (Expand Search)
higher decrease » higher degree (Expand Search), higher degrees (Expand Search), highest increase (Expand Search)
small decrease » small increased (Expand Search)
-
121
Summary of post-treatment disease course measures from MDMA-AT publications.
Published 2025Subjects: -
122
-
123
Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications.
Published 2025Subjects: -
124
-
125
-
126
-
127
Summary of post-treatment disease course measures from off-label medications clinical trials.
Published 2025Subjects: -
128
Summary of post-treatment CAPS score changes from clinical trials with psychotherapies.
Published 2025Subjects: -
129
Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes.
Published 2025Subjects: -
130
Summary of post-treatment disease course measures from clinical trials with psychotherapies.
Published 2025Subjects: -
131
-
132
-
133
Post-treatment CAPS score changes from clinical trials with off-label PTSD medications.
Published 2025Subjects: -
134
-
135
-
136
-
137
-
138
-
139
-
140
Column charts of WiAUC in therapy and control group at baseline and follow-up.
Published 2025Subjects: